Our clinical team includes Aesthetic Injectors Rebecca Fant, MSN, FNP-C and Angela Hunsaker, RN
Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in CVS Health's filings with the Securities and Exchange Commission, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in our most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and Current Reports on Form 8-K
The expected timing, dose-matching logic, and washout considerations are covered in switching from tirzepatide to retatrutide
The MHRA has taken enforcement action against illicit supply chains, including a major seizure of unlicensed weight loss pens in October 2025
Average weight loss was under 4% for those who stopped treatment early, versus nearly 7% or those who stopped later on, the study says
Aktar, R